Bioceltix (WAR:BCX) Other Operating Expense: zł14.69 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BCX Bioceltix SA WAR:BCX
27 GF Score
Price zł97.00
! 2 Warning Signs
View Full Analysis

What is Bioceltix Other Operating Expense?

Bioceltix WAR:BCX 27 Other Operating Expense is zł14.69 Mil as of Mar. 2026. GuruFocus rates WAR:BCX with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

Bioceltix's Other Operating Expense for the three months ended in Mar. 2026 was zł4.70 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was zł14.69 Mil.

Bioceltix's quarterly Other Operating Expense declined from Sep. 2025 (zł3.91 Mil) to Dec. 2025 (zł2.88 Mil) but then increased from Dec. 2025 (zł2.88 Mil) to Mar. 2026 (zł4.70 Mil).

Bioceltix's annual Other Operating Expense increased from Dec. 2023 (zł12.98 Mil) to Dec. 2024 (zł13.30 Mil) but then declined from Dec. 2024 (zł13.30 Mil) to Dec. 2025 (zł13.12 Mil).

Bioceltix Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Bioceltix's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioceltix Other Operating Expense Chart

Bioceltix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial 3.55 8.26 12.98 13.30 13.12

Bioceltix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.27 3.20 3.91 2.88 4.70
WAR:BCX
27GF Score
Bioceltix SA WAR:BCX
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioceltix Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł14.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of zł14.69 Mil mean?
Bioceltix (WAR:BCX) has a Other Operating Expense of zł14.69 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Bioceltix and its competitors.
Is Bioceltix's Other Operating Expense too high?
Bioceltix's current Other Operating Expense is zł14.69 Mil. Overall, Bioceltix has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Bioceltix's Other Operating Expense compare to VRTX and REGN?
Bioceltix's Other Operating Expense of zł14.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Bioceltix and its competitors. Bioceltix's current Other Operating Expense is zł14.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioceltix stock overvalued right now?
Bioceltix (WAR:BCX) has a current Other Operating Expense of zł14.69 Mil. The current Other Operating Expense is zł14.69 Mil. Bioceltix's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Bioceltix (WAR:BCX), the current Other Operating Expense is zł14.69 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioceltix Business Description

Address Bierutowska 57-59 Street, Wroclaw, POL, 51-317
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.
27GF Score

Get the complete analysis for WAR:BCX

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł97.00
Price